Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer

BACKGROUND: This retrospective analysis was planned as a direct comparison of taxanes plus trastuzumab to the less toxic combination of oral vinorelbine (OV) plus trastuzumab as a first-line therapy for metastatic HER2-positive breast cancer. PATIENTS AND METHODS: Patients (n = 76) receiving either...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Breast Care (Basel)
Glavni autori: Bergen, Elisabeth, Berghoff, Anna S., Rudas, Margaretha, Dubsky, Peter, De Vries, Catharina, Sattlberger, Claudia, Mader, Robert M., Zagouri, Flora, Sparber, Cornelia, Fitzal, Florian, Gnant, Michael, Rottenfusser, Andrea, Zielinski, Christoph C., Preusser, Matthias, Steger, Guenther G., Bartsch, Rupert
Format: Artigo
Jezik:Inglês
Izdano: S. Karger GmbH 2014
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4322687/
https://ncbi.nlm.nih.gov/pubmed/25759615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368330
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items